Immobilization of bioactive plasmin reduces the thrombogenicity of metal surfaces
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 136, 944-954
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (APP1033079, APP1039072)
- Australian Research Council
This publication has 40 references indexed in Scilit:
- Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent typeEuropean Heart Journal, 2014
- Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantationEuropean Heart Journal, 2014
- A novel antithrombotic coronary stent: lysine-poly(HEMA)-modified cobalt–chromium stent with fibrinolytic activityJournal of Biomaterials Science, Polymer Edition, 2012
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingCirculation, 2012
- Mimicking the fibrinolytic system on material surfacesColloids and Surfaces B: Biointerfaces, 2011
- Arterial thrombus formation in cardiovascular diseaseNature Reviews Cardiology, 2011
- Thrombolysis With PlasminStroke, 2010
- Surfaces having dual fibrinolytic and protein resistant properties by immobilization of lysine on polyurethane through a PEG spacerJournal of Biomedical Materials Research Part A, 2008
- Thrombosis: the last frontier of coronary stenting?The Lancet, 2007
- Corrosion degradation and prevention by surface modification of biometallic materialsJournal of Materials Science: Materials in Medicine, 2006